NF45, also known as ILF2 (Interleukin Enhancer Binding Factor 2), is a nuclear factor that plays a crucial role in the regulation of gene expression, particularly in the context of viral replication, cell proliferation, and the immune response. It functions as part of a heterodimeric complex with NF90/NFAR (ILF3), where it is involved in the post-transcriptional regulation of mRNA, influencing both its stability and translation. NF45 is essential for the proper functioning of the immune system, facilitating the transcription of IL-2, a key cytokine in the activation and proliferation of T-lymphocytes. Beyond its immunological roles, NF45 is implicated in the cellular response to viral infection and has been shown to be critical for the life cycle of various viruses, suggesting its function as a host factor in viral pathogenesis. The protein's involvement in diverse cellular processes underscores its importance in both normal physiological and pathological states, making it a significant target for understanding the molecular mechanisms underlying gene expression, cell cycle regulation, and the innate immune response.
The inhibition of NF45 involves mechanisms that disrupt its function in the regulation of gene expression and its interaction with NF90. Inhibitors may target the NF45-NF90 complex formation, thereby affecting the complex's ability to bind RNA and regulate its stability and translation. Such inhibition can lead to altered expression levels of genes critical for immune responses and cell proliferation, impacting cellular homeostasis and the efficacy of viral replication. Moreover, the modulation of NF45 activity can influence the cellular response to viral infection, making it a target of interest for understanding how viral and host factors interact during the course of infection. By inhibiting NF45, it is possible to elucidate the pathways through which it regulates gene expression and its role in viral pathogenesis, immune regulation, and cell cycle control, providing insights into the complex network of interactions that govern cellular function and the immune response.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can indirectly inhibit NF45 by affecting the PI3K/Akt pathway, which is involved in various cellular processes including those linked to NF45 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, potentially decreases NF45 activity by modulating the PI3K/Akt pathway, which can have downstream effects on NF45-related signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can indirectly affect NF45 by inhibiting the mTOR pathway, which is involved in cellular processes linked to NF45 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may influence NF45 activity indirectly by altering chromatin structure and gene expression patterns related to NF45. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can affect NF45 indirectly by changing DNA methylation patterns and potentially impacting NF45-related gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can indirectly modulate NF45 activity by affecting the MAPK pathway, which is linked to NF45-related signaling processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may indirectly inhibit NF45 by modulating the JNK signaling pathway, which can influence NF45-related cellular responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an MEK inhibitor, potentially decreases NF45 activity by inhibiting the MEK-ERK pathway, which is connected to NF45 signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural compound, can indirectly affect NF45 by modulating various signaling pathways including NF-κB, which may intersect with NF45-related pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone, may influence NF45 indirectly through its actions as a tyrosine kinase inhibitor, affecting signaling pathways associated with NF45. | ||||||